Literature DB >> 28775867

Crystal structure, Hirshfeld analysis and mol-ecular docking with the vascular endothelial growth factor receptor-2 of (3Z)-5-fluoro-3-(hy-droxy-imino)-indolin-2-one.

Bianca Barreto Martins1, Leandro Bresolin1, Renan Lira de Farias2, Adriano Bof de Oliveira3, Vanessa Carratu Gervini1.   

Abstract

The reaction between 5-fluoro-isatin and hydroxyl-amine hydro-chloride in acidic ethanol yields the title compound, C8H5FN2O2, whose mol-ecular structure matches the asymmetric unit and is nearly planar with an r.m.s. deviation for the mean plane through all non-H atoms of 0.0363 Å. In the crystal, the mol-ecules are linked by N-H⋯N, N-H⋯O and O-H⋯O hydrogen-bonding inter-actions into a two-dimensional network along the (100) plane, forming rings with R22 (8) and R12 (5) graph-set motifs. The crystal packing also features weak π-π inter-actions along the [100] direction [centroid-to-centroid distance 3.9860 (5) Å]. Additionally, the Hirshfeld surface analysis indicates that the major contributions for the crystal structure are the O⋯H (28.50%) and H⋯F (16.40%) inter-actions. An in silico evaluation of the title compound with the vascular endothelial growth factor receptor-2 (VEGFR-2) was carried out. The title compound and the selected biological target VEGFR-2 show the N-H⋯O(GLU94), (CYS96)N-H⋯O(isatine) and (PHE95)N-H⋯O(isatine) inter-molecular inter-actions, which suggests a solid theoretical structure-activity relationship.

Entities:  

Keywords:  Hirshfeld surface analysis; crystal structure; isatin derivative–VEGFR-2 in silico evaluation

Year:  2017        PMID: 28775867      PMCID: PMC5499275          DOI: 10.1107/S2056989017008301

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

The chemistry of isatin is already well documented due to its wide range of applications, especially in organic synthetic chemistry and medicinal chemistry. The first reports on the synthesis of isatin and isatin-based derivatives can be traced back to the first half of the 19th century (Erdmann, 1841a ▸,b ▸; Laurent, 1841 ▸) and almost one hundred years after those publications, the review ‘The Chemistry of Isatin’ showed the versatility of this mol­ecular fragment (Sumpter, 1944 ▸). Two recent examples of this are the synthesis of 1-[(2-methyl­benzimidazol-1-yl) meth­yl]-2-oxo-indolin-3-yl­idene]amino]­thio­urea, an in vitro and in silico Chikungunya virus inhibitor (Mishra et al., 2016 ▸) and 5-chloro­isatin-4-methyl­thio­semi­carbazone, an inter­mediate in the HIV-1 (human immuno­deficiency virus type 1) RT (reverse transcriptase) inhibitor (Meleddu et al., 2017 ▸). For these reasons, the crystal structure determination of isatin-based mol­ecules is an intensive research field and one of our major research aims. Herein, the structure, the Hirshfeld surface analysis and the mol­ecular docking with the vascular endothelial growth factor receptor-2 (VEGFR-2) of the 5-fluoro­isatin-3-oxime are reported.

Structural commentary

The mol­ecular structure of the title compound (Fig. 1 ▸) matches the asymmetric unit and it is nearly planar with an r.m.s. deviation from the mean plane of the non–H atoms of 0.0363 Å [from −0.0806 (9) Å for atom O2 to 0.0575 (11) Å for atom C2]. The C1—C2—N2—O2 and C3—C2—N2—O2 torsion angles are −174.24 (10) and −0.5 (2)°, respectively.
Figure 1

The mol­ecular structure of the title compound with displacement ellipsoids drawn at the 40% probability level.

Supra­molecular features and Hirshfeld surface analysis

In the crystal, the mol­ecules are connected by centrosymmetric pairs of N1—H4⋯O1 [symmetry code: (i) −x + 1, −y + 2, −z + 1] inter­molecular inter­actions into dimers with graph-set motif R(8) (Table 1 ▸). In addition, a remarkable feature consists in an asymmetric bifurcated hydrogen bond with graph-set motif R(5) involving the H5 atom of the oxime group and the O1ii and N2ii atoms of a neighboring mol­ecule [symmetry code: (ii) −x + 1, y − , −z + ]. These two hydrogen bonds, which form rings with motifs R(8) and R(5), connect the mol­ecules into a two-dimensional, tape-like network parallel to the (100) plane. Finally, the mol­ecules are stacked along the [100] direction by weak π–π inter­actions (Fig. 2 ▸) between the benzene and the indolic five-membered rings. The centroid-to-centroid distance is 3.9860 (5) Å).
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
N1—H4⋯O1i 0.91 (2)1.96 (2)2.8487 (16)164.7 (18)
O2—H5⋯N2ii 0.99 (3)2.69 (2)3.2989 (16)120.2 (18)
O2—H5⋯O1ii 0.99 (3)1.77 (3)2.7280 (15)163 (2)

Symmetry codes: (i) ; (ii) .

Figure 2

Crystal structure of the title compound viewed along the [010] direction. The H⋯O and H⋯N inter­actions in the crystal packing are shown as dashed lines and connect the mol­ecules into a two-dimensional H-bonded network along the (100) plane. The Cg⋯Cg packing along the [100] direction is also shown as dashed lines.

The Hirshfeld surface analysis (Hirshfeld, 1977 ▸) of the crystal structure for the title compound was performed. The surface graphical representation, d, with transparency and labelled atoms indicates, in magenta colour, the locations of the strongest inter­molecular contacts, e.g. H4, H5 and O1, which are important for the inter­molecular hydrogen bonding (Fig. 3 ▸ a). The Hirshfeld analysis suggests that the major contributions for the crystal packing amount to 25.40% for H⋯O, 16.40% for H⋯F and 16.10% for H⋯H inter­actions. Other important inter­molecular contacts for the cohesion of the structure are (values given in %): C⋯C = 11.30, H⋯N = 9.80 and H⋯C = 6.40 (Wolff et al., 2012 ▸; Fig. 4 ▸).
Figure 3

The Hirshfeld surface graphical representation (d) for the asymmetric unit of (a) the title compound, 5-fluoro­isatin-3-oxime, and (b) the comparison compound, 5-chloro­isatin-3-oxime (Martins et al., 2016 ▸). The surface regions with strongest inter­molecular inter­actions are drawn in magenta colour.

Figure 4

Hirshfeld surface two-dimensional fingerprint plots for the title compound showing the (a) H⋯O, (b) H⋯F, (c) H⋯H, (d) C⋯C, (e) H⋯N and (f) H⋯C contacts in detail (cyan dots). The contributions of the inter­actions to the crystal packing amount to 25.40%, 16.40%, 16.10%, 11.30%, 9.80% and 6.40%, respectively. The d (y axis) and d (x axis) values are the closest external and inter­nal distances (values in Å) from given points on the Hirshfeld surface contacts.

Comparison with a related structure

For a comparison with the title compound, 5-fluoro­isatin-3-oxime, the structure of the related compound 5-chloro­isatin-3-oxime (Martins et al., 2016 ▸) was selected. Both structures are nearly planar, build a two-dimensional hydrogen-bonded network parallel to the (100) plane and show the mol­ecules stacked along the [100] direction. The Hirshfeld surface analysis (Hirshfeld, 1977 ▸) for 5-chloro­isatin-3-oxime was carried out and the Hirshfeld surface graphical representation, d, with transparency and labelled atoms indicates, in magenta colour, the locations of the strongest inter­molecular contacts, e.g. H1, H5 and O1 (Fig. 3 ▸ b). Although the crystal packing (Figs. 2 ▸ and 5 ▸) and the Hirshfeld surface graphical representations (Fig. 3 ▸ a,b) for the title compound and the 5-chloro­isatin-3-oxime are quite similar, the contributions of the inter­molecular inter­actions to the cohesion of the crystal structures have differences due to the halogen substituents. For example: for 5-chloro­isatin-3-oxime, the H⋯O inter­action amounts to 23.60% and the H⋯Cl inter­action amounts to 18.10%. The contributions to the crystal packing are shown as Hirshfeld surface two-dimensional fingerprint plots with cyan dots. The d (y axis) and d (x axis) values are the closest external and inter­nal distances (Å) from given points on the Hirshfeld surface contacts (Figs. 4 ▸ and 6 ▸; Wolff et al., 2012 ▸).
Figure 5

Crystal structure of the comparison compound 5-chloro­isatin-3-oxime (Martins et al., 2016 ▸), viewed along the [010] direction.

Figure 6

Hirshfeld surface two-dimensional fingerprint plots for the comparison compound 5-chloro­isatin-3-oxime (Martins et al., 2016 ▸) showing the (a) H⋯O and (b) H⋯Cl contacts in detail (cyan dots). The contributions of the inter­actions to the crystal packing amount to 23.60% and 18.10%. The d (y axis) and d (x axis) values are the closest external and inter­nal distances (values in Å) from given points on the Hirshfeld surface contacts.

Mol­ecular docking evaluation

For a lock-and-key supra­molecular analysis, a mol­ecular docking evaluation between the title compound and the vascular endothelial growth factor receptor-2 (VEGFR-2) was carried out. Initially, the semi-empirical equilibrium energy of the small mol­ecule was obtained using the PM6 Hamiltonian, but the experimental bond lengths were conserved. The calculated parameters were: heat of formation = −49.353 kJ mol−1, gradient normal = 0.90997, HOMO = −9.265 eV, LUMO = −1.337 eV and energy gap = 7.928 eV (Macrae et al., 2008 ▸; Stewart, 2013 ▸, 2016 ▸). The biological target prediction for the title compound was calculated with the SwissTargetPrediction webserver based on the bioisosteric similarity to the isatin entity (Gfeller et al., 2013 ▸, 2014 ▸). As result of this screening, the title compound showed a promising theoretical structure–activity relationship to kinase proteins sites: ‘Frequency Target Class’ for kinases amounts to 33% [see the ‘SwissTargetPrediction report (5-fluoro­isatin-3-oxime)’ in the Supporting information]. The protein kinases regulate several critical cellular processes (Wang & Cole, 2014 ▸) and the vascular endothelial growth factor receptor-2 kinase inhibition is becoming an attractive subject for anti­cancer drug research (Gao et al., 2015 ▸). The crystal structure of the vascular endothelial growth factor receptor-2 (VEGFR-2), PDB ID: 3WZD, was downloaded from Protein Data Bank (Okamoto et al., 2015 ▸). Before the calculations, a stereochemical evaluation of the protein structure was carried out using the Ramachandran analysis (Lovell et al., 2003 ▸) and the number of residues in favoured regions for inter­molecular inter­actions was over 98% [see the ‘Number of residues in favoured region (VEGFR-2)’ in the Supporting information]. The docking simulation was performed with the GOLD 5.5 software (Chen, 2015 ▸) and a grid of 25 Å was centered on the binding site of Levatinib in the VEGFR-2 kinase (Okamoto et al., 2015 ▸). A redocking of the Levatinib compound, an oral multikinase inhibitor that selectively inhibits the vascular endothelial growth factor-2, was used as validation method for the mol­ecular docking protocol (see the ‘Re-docking of the Lenvatinib (kinase inhibitor and FDA approved drug)’ in the Supporting information]. A calculated global free energy of −20.49 kJ mol−1 was found for the title compound and the selected biological target VEGFR-2 inter­action and the structure–activity relationship can be assumed by the following observed inter­molecular inter­actions, with the respective hydrogen-bond distances and angles: N—H⋯O(GLU94) [H⋯O = 2.03 Å, N—H⋯O = 174°], (CYS96)N—H⋯O(isatine) [H⋯O = 1.72 Å, N—H⋯O = 168°] and (PHE95)C—H⋯O(isatine) [H⋯O = 2.27 Å, C—H⋯O = 140°] (Fig. 7 ▸). Another significant feature of the structure of the title compound is the oxygen atom of the isatin fragment. The O1 atom is a hydrogen-bond acceptor and bridges two D—H⋯O inter­actions (supra­molecular chemistry, Fig. 2 ▸; Hirshfeld surface, Fig. 3 ▸; mol­ecular docking with the biological target VEGFR-2 kinase, Fig. 7 ▸).
Figure 7

Graphical representation of a lock-and-key model for the inter­molecular inter­actions between the title compound and selected residues of the VEGFR-2. The inter­actions are shown as dashed lines and the structure of the enzyme is simplified for clarity.

Synthesis and crystallization

All starting materials are commercially available and were used without further purification. The synthesis of the title compound was adapted from procedures reported previously (Martins et al., 2016 ▸; O’Sullivan & Sadler, 1956 ▸; Sandmeyer, 1919 ▸; Sumpter, 1944 ▸). A glacial acetic acid catalyzed mixture of 5-fluoro­isatin (3 mmol) and hydroxyl­amine hydro­chloride (3 mmol) in ethanol (50 mL) was stirred and refluxed for 6 h. After cooling and filtering, single crystals suitable for X-ray diffraction were obtained from the ethano­lic solution by solvent evaporation.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. The H4 and H5 atoms were located in a difference Fourier map and freely refined [N1—H4 = 0.91 (2) Å and O2—H5 = 0.99 (3) Å]. The H1, H2 and H3 atoms were positioned with idealized geometry (HFIX command) and refined using a riding model, with C—H = 0.95 Å and U iso(H) = 1.2U eq(C).
Table 2

Experimental details

Crystal data
Chemical formulaC8H5FN2O2
M r 180.14
Crystal system, space groupMonoclinic, P21/c
Temperature (K)200
a, b, c (Å)7.3036 (10), 7.2045 (10), 14.009 (2)
β (°)94.736 (4)
V3)734.61 (18)
Z 4
Radiation typeMo Kα
μ (mm−1)0.14
Crystal size (mm)0.34 × 0.32 × 0.06
 
Data collection
DiffractometerBruker APEXII CCD area detector
Absorption correctionMulti-scan (SADABS; Krause et al., 2015)
T min, T max 0.663, 0.746
No. of measured, independent and observed [I > 2σ(I)] reflections8386, 2142, 1687
R int 0.021
(sin θ/λ)max−1)0.705
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.040, 0.108, 1.05
No. of reflections2142
No. of parameters126
H-atom treatmentH atoms treated by a mixture of independent and constrained refinement
Δρmax, Δρmin (e Å−3)0.30, −0.21

Computer programs: APEX2 and SAINT (Bruker, 2014 ▸), SHELXT2014/4 (Sheldrick, 2015a ▸), SHELXL2016/6 (Sheldrick, 2015b ▸), WinGX (Farrugia, 2012 ▸), DIAMOND (Brandenburg, 2006 ▸), GOLD (Chen et al., 2015 ▸), MOPAC (Stewart, 2016 ▸), CRYSTAL EXPLORER (Wolff, et al., 2012 ▸), publCIF (Westrip, 2010 ▸) and enCIFer (Allen et al., 2004 ▸).

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989017008301/rz5215sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989017008301/rz5215Isup2.hkl SwissTargetPrediction report (5-flouroisatin-3-oxime). DOI: 10.1107/S2056989017008301/rz5215sup3.pdf Number of residues in favoured region (VEGFR-2). DOI: 10.1107/S2056989017008301/rz5215sup4.pdf Re-docking of the Lenvatinib (kinase inhibitor and FDA approved drug). DOI: 10.1107/S2056989017008301/rz5215sup5.pdf Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989017008301/rz5215Isup6.cml CCDC reference: 1554287 Additional supporting information: crystallographic information; 3D view; checkCIF report
C8H5FN2O2F(000) = 368
Mr = 180.14Dx = 1.629 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
a = 7.3036 (10) ÅCell parameters from 3387 reflections
b = 7.2045 (10) Åθ = 2.8–30.0°
c = 14.009 (2) ŵ = 0.14 mm1
β = 94.736 (4)°T = 200 K
V = 734.61 (18) Å3Plate, yellow
Z = 40.34 × 0.32 × 0.06 mm
Bruker APEXII CCD area detector diffractometer1687 reflections with I > 2σ(I)
Radiation source: fine-focus sealed X-ray tubeRint = 0.021
φ and ω scansθmax = 30.1°, θmin = 2.8°
Absorption correction: multi-scan (SADABS; Krause et al., 2015)h = −10→10
Tmin = 0.663, Tmax = 0.746k = −10→7
8386 measured reflectionsl = −19→19
2142 independent reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.040Hydrogen site location: mixed
wR(F2) = 0.108H atoms treated by a mixture of independent and constrained refinement
S = 1.05w = 1/[σ2(Fo2) + (0.0428P)2 + 0.3741P] where P = (Fo2 + 2Fc2)/3
2142 reflections(Δ/σ)max < 0.001
126 parametersΔρmax = 0.30 e Å3
0 restraintsΔρmin = −0.21 e Å3
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
xyzUiso*/Ueq
C10.40095 (17)0.78184 (19)0.56663 (9)0.0247 (3)
C20.34449 (16)0.59266 (19)0.59782 (9)0.0225 (3)
C30.25830 (15)0.49961 (19)0.51303 (8)0.0219 (3)
C40.18138 (17)0.3250 (2)0.49698 (10)0.0263 (3)
H10.1761750.2363600.5468690.032*
C50.11244 (18)0.2879 (2)0.40349 (10)0.0297 (3)
C60.11742 (18)0.4116 (2)0.32854 (10)0.0306 (3)
H20.0685960.3776530.2660220.037*
C70.19449 (18)0.5867 (2)0.34516 (9)0.0277 (3)
H30.1997490.6744480.2948470.033*
C80.26306 (16)0.62779 (19)0.43768 (9)0.0227 (3)
F10.03607 (14)0.11739 (14)0.38491 (7)0.0459 (3)
N10.34730 (16)0.79375 (17)0.47154 (8)0.0261 (3)
N20.39084 (15)0.54652 (17)0.68513 (8)0.0262 (3)
O10.48449 (15)0.90064 (15)0.61615 (7)0.0324 (3)
O20.34792 (15)0.36593 (15)0.70338 (7)0.0340 (3)
H40.384 (3)0.889 (3)0.4351 (15)0.046 (5)*
H50.409 (3)0.352 (3)0.7684 (18)0.073 (7)*
U11U22U33U12U13U23
C10.0267 (6)0.0261 (7)0.0210 (6)0.0027 (5)0.0005 (4)−0.0002 (5)
C20.0219 (5)0.0254 (7)0.0201 (6)0.0032 (5)0.0008 (4)−0.0008 (5)
C30.0190 (5)0.0268 (7)0.0197 (5)0.0034 (5)0.0007 (4)−0.0020 (5)
C40.0241 (6)0.0297 (7)0.0249 (6)0.0013 (5)0.0013 (4)−0.0016 (5)
C50.0261 (6)0.0307 (8)0.0318 (7)−0.0015 (5)−0.0006 (5)−0.0086 (6)
C60.0262 (6)0.0418 (9)0.0230 (6)0.0020 (6)−0.0030 (5)−0.0077 (6)
C70.0248 (6)0.0375 (8)0.0202 (6)0.0031 (5)−0.0013 (4)0.0005 (5)
C80.0197 (5)0.0280 (7)0.0203 (6)0.0037 (5)0.0006 (4)−0.0008 (5)
F10.0545 (6)0.0398 (6)0.0416 (5)−0.0143 (4)−0.0063 (4)−0.0097 (4)
N10.0310 (5)0.0262 (6)0.0204 (5)−0.0006 (5)−0.0023 (4)0.0032 (4)
N20.0293 (5)0.0279 (6)0.0214 (5)0.0006 (4)0.0010 (4)0.0018 (4)
O10.0454 (6)0.0279 (6)0.0230 (5)−0.0052 (4)−0.0025 (4)−0.0014 (4)
O20.0434 (6)0.0314 (6)0.0263 (5)−0.0062 (4)−0.0029 (4)0.0069 (4)
C1—O11.2313 (16)C5—C61.380 (2)
C1—N11.3599 (16)C6—C71.393 (2)
C1—C21.4994 (19)C6—H20.9500
C2—N21.2857 (16)C7—C81.3825 (18)
C2—C31.4605 (17)C7—H30.9500
C3—C41.3883 (19)C8—N11.4089 (18)
C3—C81.4051 (18)N1—H40.91 (2)
C4—C51.3898 (19)N2—O21.3674 (16)
C4—H10.9500O2—H50.99 (3)
C5—F11.3651 (17)
O1—C1—N1126.68 (13)C5—C6—C7119.57 (12)
O1—C1—C2127.09 (12)C5—C6—H2120.2
N1—C1—C2106.19 (11)C7—C6—H2120.2
N2—C2—C3135.81 (13)C8—C7—C6117.44 (13)
N2—C2—C1117.07 (12)C8—C7—H3121.3
C3—C2—C1106.90 (10)C6—C7—H3121.3
C4—C3—C8120.57 (12)C7—C8—C3122.27 (13)
C4—C3—C2133.56 (12)C7—C8—N1127.72 (13)
C8—C3—C2105.88 (12)C3—C8—N1110.00 (11)
C3—C4—C5115.94 (13)C1—N1—C8111.02 (11)
C3—C4—H1122.0C1—N1—H4121.6 (13)
C5—C4—H1122.0C8—N1—H4126.2 (13)
F1—C5—C6118.18 (12)C2—N2—O2112.17 (11)
F1—C5—C4117.62 (14)N2—O2—H5100.2 (15)
C6—C5—C4124.20 (14)
O1—C1—C2—N2−1.5 (2)C5—C6—C7—C8−0.05 (19)
N1—C1—C2—N2176.30 (12)C6—C7—C8—C30.59 (19)
O1—C1—C2—C3−176.99 (13)C6—C7—C8—N1179.71 (12)
N1—C1—C2—C30.84 (13)C4—C3—C8—C7−0.73 (18)
N2—C2—C3—C45.3 (2)C2—C3—C8—C7179.29 (11)
C1—C2—C3—C4179.49 (13)C4—C3—C8—N1−179.98 (11)
N2—C2—C3—C8−174.73 (14)C2—C3—C8—N10.04 (14)
C1—C2—C3—C8−0.53 (13)O1—C1—N1—C8177.00 (13)
C8—C3—C4—C50.28 (18)C2—C1—N1—C8−0.83 (14)
C2—C3—C4—C5−179.75 (13)C7—C8—N1—C1−178.67 (12)
C3—C4—C5—F1179.86 (11)C3—C8—N1—C10.53 (15)
C3—C4—C5—C60.3 (2)C3—C2—N2—O2−0.5 (2)
F1—C5—C6—C7−179.98 (12)C1—C2—N2—O2−174.24 (10)
C4—C5—C6—C7−0.4 (2)
D—H···AD—HH···AD···AD—H···A
N1—H4···O1i0.91 (2)1.96 (2)2.8487 (16)164.7 (18)
O2—H5···N2ii0.99 (3)2.69 (2)3.2989 (16)120.2 (18)
O2—H5···O1ii0.99 (3)1.77 (3)2.7280 (15)163 (2)
  12 in total

1.  Structure validation by Calpha geometry: phi,psi and Cbeta deviation.

Authors:  Simon C Lovell; Ian W Davis; W Bryan Arendall; Paul I W de Bakker; J Michael Word; Michael G Prisant; Jane S Richardson; David C Richardson
Journal:  Proteins       Date:  2003-02-15

2.  Shaping the interaction landscape of bioactive molecules.

Authors:  David Gfeller; Olivier Michielin; Vincent Zoete
Journal:  Bioinformatics       Date:  2013-09-17       Impact factor: 6.937

3.  Discovery of novel VEGFR-2 inhibitors. Part II: biphenyl urea incorporated with salicylaldoxime.

Authors:  Hongping Gao; Ping Su; Yaling Shi; Xiuxiu Shen; Yanmin Zhang; Jinyun Dong; Jie Zhang
Journal:  Eur J Med Chem       Date:  2014-11-18       Impact factor: 6.514

Review 4.  Beware of docking!

Authors:  Yu-Chian Chen
Journal:  Trends Pharmacol Sci       Date:  2014-12-24       Impact factor: 14.819

5.  Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization.

Authors:  Kiyoshi Okamoto; Megumi Ikemori-Kawada; Anja Jestel; Konstanze von König; Yasuhiro Funahashi; Tomohiro Matsushima; Akihiko Tsuruoka; Atsushi Inoue; Junji Matsui
Journal:  ACS Med Chem Lett       Date:  2014-11-17       Impact factor: 4.345

6.  Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters.

Authors:  James J P Stewart
Journal:  J Mol Model       Date:  2012-11-28       Impact factor: 1.810

7.  Comparison of silver and molybdenum microfocus X-ray sources for single-crystal structure determination.

Authors:  Lennard Krause; Regine Herbst-Irmer; George M Sheldrick; Dietmar Stalke
Journal:  J Appl Crystallogr       Date:  2015-01-30       Impact factor: 3.304

8.  SHELXT - integrated space-group and crystal-structure determination.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A Found Adv       Date:  2015-01-01       Impact factor: 2.290

9.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

10.  Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase.

Authors:  Rita Meleddu; Simona Distinto; Angela Corona; Enzo Tramontano; Giulia Bianco; Claudia Melis; Filippo Cottiglia; Elias Maccioni
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-21       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.